Refine Search
(2)
(19)
(66)
(96)

Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2018’, provides an overview of the Middle East Respiratory Syndrome (MERS) pipeline landscape.

The report provides comprehensive information on the t...

Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tinea pedis (Athlete Foot) - Pipeline Review, H1 2018’, provides an overview of the Tinea pedis (Athlete Foot) pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Toxoplasmosis - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Toxoplasmosis - Pipeline Review, H1 2018’, provides an overview of the Toxoplasmosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Toxoplasmosis, com...

Western Equine Encephalitis - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Western Equine Encephalitis - Pipeline Review, H1 2018’, provides an overview of the Western Equine Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2018’, provides an overview of the Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infect...

Escherichia coli Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Escherichia coli Infections - Pipeline Review, H1 2018’, provides an overview of the Escherichia coli Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Malaria - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2018’, provides an overview of the Malaria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Malaria, complete with analysi...

Diphtheria - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diphtheria - Pipeline Review, H1 2018’, provides an overview of the Diphtheria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diphtheria, complete wit...

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2018’, provides an overview of the Respiratory Syncytial Virus (RSV) Infections pipeline landscape.

The report provides comprehensive informatio...

Hepatitis B - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatitis B - Pipeline Review, H1 2018’, provides an overview of the Hepatitis B pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hepatitis B, complete ...

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018’, provides an overview of the Methicillin-Resistant Staphylococcus aureus (MRSA) Infections pipeline landscape.

The report...

Tuberculosis - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2018’, provides an overview of the Tuberculosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tuberculosis, comple...

Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2018’, provides an overview of the Burkholderia pseudomallei Infections (Melioidosis) pipeline landscape.

The report provides comprehensiv...

Kaposi Sarcoma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kaposi Sarcoma - Pipeline Review, H1 2018’, provides an overview of the Kaposi Sarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Kaposi Sarcoma, ...

Rubella (German Measles) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rubella (German Measles) - Pipeline Review, H1 2018’, provides an overview of the Rubella (German Measles) pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...